tiprankstipranks
Trending News
More News >

New Portfolio Jan 2023 - New Portfolio

Assen

New Portfolio Jan 2023
Individual Investor
Ranked #509,003 out of 815,805 TipRanks' Investors
Success Rate
41%
46 out of 113
profitable transactions
Average Return
-0.17%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.38%
6-Month Return▼ 4.90%
12-Month Return▼ 1.19%
YTD Return▲ 2.99%
Total Return▲ 6.09%

Best Trade

Opened at
Closed at-
Gain▲ 286.58%

Bio

LT focused portfolio with primary investment in EU based companies

Performance

27.88%0-27.88%
▲ 6.03%
▲ 2.69%
▲ 7.21%
Jan 2025
▼ 12.86%
▼ 1.27%
▲ 1.01%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 9.94%
Mar 2025
▲ 1.84%
▼ 0.87%
▼ 3.30%
Apr 2025
▲ 12.20%
▲ 6.28%
▲ 2.80%
May 2025
▲ 6.24%
▲ 5.14%
▼ 1.52%
Jun 2025
▲ 27.88%
▲ 2.30%
▲ 2.85%
Jul 2025
▲ 6.52%
▲ 2.30%
▲ 4.88%
Aug 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 6.03%▲ 2.69%▲ 7.21%
▼ 12.86%▼ 1.27%▲ 1.01%
▼ 1.80%▼ 5.57%▼ 9.94%
▲ 1.84%▼ 0.87%▼ 3.30%
▲ 12.20%▲ 6.28%▲ 2.80%
▲ 6.24%▲ 5.14%▼ 1.52%
▲ 27.88%▲ 2.30%▲ 2.85%
▲ 6.52%▲ 2.30%▲ 4.88%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Sanofi
0%
▼ 1.28%
4
Sell
Aug 17, 2025
Kering SA
0%
▼ 35.64%
6
Sell
Aug 17, 2025
Novo Nordisk
21.97%
▼ 32.07%
8
Buy
Aug 17, 2025
The Estée Lauder Companies
0%
▼ 17.09%
7
Sell
Aug 17, 2025
Tesla
8.18%
▲ 40.35%
3
Buy
Aug 17, 2025
Nvidia
8.52%
▲ 115.12%
5
Buy
Aug 17, 2025
EssilorLuxottica SA
5.8%
▲ 17.71%
3
Buy
Aug 17, 2025
LVMH Moet Hennessy Louis Vuitton
11.77%
▼ 12.35%
4
Buy
Aug 17, 2025
Barry Callebaut AG
0%
▼ 31.56%
2
Sell
Aug 17, 2025
Eli Lilly & Co
5.75%
▲ 3.92%
1
Open
Aug 17, 2025
Remy Cointreau
1.49%
▼ 43.06%
7
Buy
May 14, 2025
Brown Forman A
0.69%
▼ 35.34%
4
Buy
May 14, 2025
L'Oreal
3.69%
▼ 0.25%
2
Buy
May 14, 2025
TotalEnergies SE
4.87%
▼ 6.71%
2
Buy
May 14, 2025
Air Liquide
▲ 24.74%
4
Close
Sep 27, 2024
Ferrari
0%
▲ 6.02%
2
Sell
Sep 27, 2024
AXA SA
0%
▲ 24.77%
2
Sell
Sep 27, 2024
Alibaba
0%
▲ 40.25%
2
Sell
Sep 27, 2024
Compagnie Financiere Richemont SA
▼ 5.60%
2
Close
Sep 27, 2024
Bristol-Myers Squibb
0%
▲ 14.21%
2
Sell
Sep 27, 2024